BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16614935)

  • 1. CAGE displays oncogenic potential and induces cytolytic T lymphocyte activity.
    Shim E; Shim H; Bae J; Lee H; Jeoung D
    Biotechnol Lett; 2006 Apr; 28(7):515-22. PubMed ID: 16614935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CAGE, a novel cancer/testis antigen, in various cellular processes, including tumorigenesis, cytolytic T lymphocyte induction, and cell motility.
    Kim Y; Jeoung D
    J Microbiol Biotechnol; 2008 Mar; 18(3):600-10. PubMed ID: 18388483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.
    Kiessling MK; Klemke CD; Kaminski MM; Galani IE; Krammer PH; Gülow K
    Cancer Res; 2009 Mar; 69(6):2365-74. PubMed ID: 19258503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
    Yang X; Chu Y; Wang Y; Zhang R; Xiong S
    J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species promote raft formation in T lymphocytes.
    Lu SP; Lin Feng MH; Huang HL; Huang YC; Tsou WI; Lai MZ
    Free Radic Biol Med; 2007 Apr; 42(7):936-44. PubMed ID: 17349922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S; Lee JB; Lee GK; Chang J
    Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
    Nagamine I; Yamaguchi Y; Ohara M; Ikeda T; Okada M
    Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of reactive oxygen species/c-Jun NH(2)-terminal kinase pathway in kotomolide A induces apoptosis in human breast cancer cells.
    Kuo PL; Chen CY; Tzeng TF; Lin CC; Hsu YL
    Toxicol Appl Pharmacol; 2008 Jun; 229(2):215-26. PubMed ID: 18374381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox modulation inhibits CD8 T cell effector function.
    Sklavos MM; Tse HM; Piganelli JD
    Free Radic Biol Med; 2008 Nov; 45(10):1477-86. PubMed ID: 18805480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth.
    Kim EY; Teh SJ; Yang J; Chow MT; Teh HS
    J Immunol; 2009 Nov; 183(10):6051-7. PubMed ID: 19841176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.
    Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species.
    Alexandre J; Hu Y; Lu W; Pelicano H; Huang P
    Cancer Res; 2007 Apr; 67(8):3512-7. PubMed ID: 17440056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil-sensitive Ca2+ channel regulation of Th1-type proliferation of splenic lymphocytes induced by Walker 256 tumor development in rats.
    Degasperi GR; Zecchin KG; Borecký J; Cruz-Höfling MA; Castilho RF; Velloso LA; Guimarães F; Vercesi AE
    Eur J Pharmacol; 2006 Nov; 549(1-3):179-84. PubMed ID: 16996495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for DHX32 in regulating T-cell apoptosis.
    Alli Z; Chen Y; Abdul Wajid S; Al-Saud B; Abdelhaleem M
    Anticancer Res; 2007; 27(1A):373-7. PubMed ID: 17352256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune modulation and apoptosis induction: Two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera.
    Malik F; Kumar A; Bhushan S; Mondhe DM; Pal HC; Sharma R; Khajuria A; Singh S; Singh G; Saxena AK; Suri KA; Qazi GN; Singh J
    Eur J Cancer; 2009 May; 45(8):1494-509. PubMed ID: 19269163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.